Medication info
Arappen Tablet

Arappen Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pale yellow, rectangular film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200707944 · Notified 2007.07.10 · Insurance code 693900300

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years or older and adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. The recommended initial dose is 2 tablets. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to alleviate acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years or older and adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. The recommended initial dose is 2 tablets. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three alcoholic drinks a day, so it is essential to consult a physician or pharmacist. If significant skin reactions such as skin rashes or itching occur while taking this medication, discontinue use immediately and seek medical attention. Patients with a history of seizures or those taking medications that may induce seizures should use this drug with caution due to the risk of seizures. Administration in patients with acute and severe asthma may pose life-threatening risks and should only be done in a facility equipped for such care. Combining this medication with alcohol or central nervous system depressants can cause severe drowsiness, respiratory depression, and coma, so such combinations should be avoided. Patients with increased intracranial pressure or head injuries may see worsened symptoms with use of this medication, therefore caution is necessary. This medication may result in psychological and physical dependence, thus long-term use should be under a physician's guidance. Patients with impaired liver function should be cautious as one of the ingredients may strain the liver, and consultation with a physician is required before use. Patients with specific genetic metabolic characteristics may experience elevated levels of the active ingredient, leading to severe respiratory depression, so caution is advised. This medication is not to be administered to children under the age of 12 or to certain postoperative pediatric patients. Patients with sleep apnea or hypoxia should be closely monitored as symptoms may worsen during use of this medication. Drowsiness or dizziness may occur while taking this medication, so caution is advised while driving or operating machinery. Overdose may lead to serious side effects such as respiratory depression, seizures, and liver damage, so it is crucial to adhere to prescribed dosages and seek medical help for any unusual symptoms. Using this medication alongside other analgesics or drugs containing acetaminophen increases the risk of liver damage, so such combinations should be avoided. Women who are pregnant or breastfeeding must consult a physician before taking this medication, as it may be transmitted through breast milk and pose risks to the baby. If any allergic reactions or breathing difficulties occur during use of this medication, notify medical personnel immediately. This medication may interact with various other drugs, so inform your physician or pharmacist of any other medications currently being taken. Elderly patients may have weaker liver, kidney, or heart functions, so they should be observed more closely while taking this medication. This medication should be stored in a safe place out of the reach of children, and precautions should be taken to prevent misuse by others.

Side effects

Liver damage, acute generalized pustular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, respiratory suppression, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, reduced libido, sleep disorders, confusion, disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory reduction, tremor, paresthesia, attention disorder, syncope, memory impairment, hyperactivity, sedation, amnesia, perceptual disturbance, convulsions, blurred vision, visual impairment, pupil constriction, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disturbance, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, affected emotional instability, delirium, suicidal thoughts, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue, glutamic acid acidosis, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, migraine exacerbation, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal renal function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, decreased appetite, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, arrhythmia, worsening hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, constipation, vomiting, indigestion, abdominal pain, dry mouth, diarrhea, drowsiness, insomnia, decreased appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, hypertension, arrhythmia, tachycardia, worsening hypertension, gastrointestinal bleeding, weight loss, tinnitus, chills, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, paralytic ileus, cholecystitis, confusion, nausea, dizziness, dyspnea, seizures, heart attack, death, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulopathy, abdominal discomfort, lethargy, pallor, increased sweating, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, acute or chronic adrenal insufficiency, symptoms of adrenal insufficiency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that prevents air from entering and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow, rectangular film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.